BL-918 (compound 33i) 是一种具有口服活性 UNC-51 样激酶 1 (ULK1) 激活剂，EC50 为 24.14 nM。BL-918 通过靶向 ULK 复合物发挥其细胞保护性自噬作用。BL-918 有用于帕金森氏病 (PD) 的潜力。
货号:ajcx16706
CAS:2101517-69-3
分子式:C23H15F8N3OS
分子量：533.44
溶解度:DMSO: ≥ 250 mg/mL (468.66 mM)
纯度：98%
存储：Store at -20°C
库存： 现货

Background:

BL-918 (compound 33i) is an orally active UNC-51-like kinase 1 (ULK1) activator with an EC50 of 24.14 nM. BL-918 exerts its cytoprotective autophagic effect by targeting ULK complex. BL-918 has the potential for Parkinson's disease (PD) treatment[1].

[1]. Ouyang L, et al. Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson's Disease Treatment. J Med Chem. 2018 Apr 12;61(7):2776-2792.